Close

Medac GmbH Advances Pharmacovigilance Technology for Safety Monitoring of its Drugs with ArisGlobal Solutions

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

– Leave Message for Us to Get Back

Related stories

Why Early Intervention Is Key To Managing Chronic Health Concerns

Proactive health management is essential for maintaining a good...

McKesson Acquires Controlling Stake in PRISM Vision

McKesson Corporation has announced its agreement to acquire a...

Pharmacy’s Impact on Reducing Medication Errors in Hospital Settings

Medication errors are a big problem in healthcare because...

How to Dispose of Pharmaceutical Waste

Proper pharmaceutical waste disposal is crucial for protecting our...

ArisGlobal, a market-leader in global drug development technology solutions, announced that medac, a German-based pharmaceutical manufacturer specializing in the fields of oncology and hematology, urology, and autoimmune diseases, has chosen LifeSphere Safety to modernize its drug safety processes. Precise, patient- and population-specific analysis is crucial for minimizing treatment risks for patients and thus supports the best possible treatment outcome.

“ArisGlobal’s Safety solutions will significantly advance the automatization of adverse event management and intelligent safety analysis and will support us in making pharmacovigilance processes even smarter and more efficient,” said Doctor Nadine Schreiber, Head of Global Pharmacovigilance of medac.

medac will launch three products from LifeSphere Safety, including its flagship solution for automated case processing, LifeSphere MultiVigilance, along with Reporting and Analytics, and EV Triage.

“LifeSphere has been developed with organizations like medac in mind; to meet global compliance, provide next-level safety insights, and operate with greater efficiency,” shares Aman Wasan, Chief Commercial Officer, ArisGlobal. “We are pleased that medac has entrusted LifeSphere products to continue their advancement of therapeutic development processes. We are confident that medac will see incredible benefit to onboarding these solutions and positively impact safety analysis at scale.”

Visit ArisGlobal at the 2023 World Drug Safety Congress Europe (Booth 19) and Americas (Booth 202) to learn more about LifeSphere Safety and Data & Analytics solutions.
>>>

Latest stories